Sub menu

 
 

COVID-19 rapid antigen self-tests that are approved in Australia

A list of self-tests that are approved in Australia

Last updated

We have approved the following COVID-19 self-tests (home use tests) for supply in Australia from 1 November 2021.

Some, but not all manufacturers of approved rapid antigen tests (RATs) have extended the shelf-life of their products. We will update the table below as we receive further information on the extended shelf-life from the sponsor.

This information is provided for health services and distributors of these tests to verify whether we have accepted a shelf-life extension for that RAT, so they can contact their supplier to clarify the expiry date for their stock of RATs.

This information is not intended for users or the general public to determine the expiry date of their RAT. The list does not specify the expiry date for individual batches of RATs from that manufacturer.

Users are advised to not use a RAT after its expiry date (or use by date). You should contact the customer support number on the 'Instructions For Use' if you are unsure about using the test or its expiry date.

It is important to follow the instructions for the specific test you do. Instructions for each test are provided in the below table.

COVID-19 rapid antigen self-tests (for home use) provides more information on:

  • where to buy rapid antigen self-tests, what to look for and how to use them correctly
  • what to do if you are travelling overseas with a COVID-19 self-test
  • reporting a problem or issue with a COVID-19 self-test
  • how you can legally supply and advertise COVID-19 self-tests in Australia.

COVID-19 nucleic acid amplification self-tests (for home use) are also approved for supply in Australia. Nucleic acid amplification (NAA) tests detect the genetic material from the SARS-CoV-2 virus, rather than the spike protein detected by rapid antigen tests during active infection.

Our performance requirements for COVID-19 self-tests are internationally aligned with technical specifications published by the World Health Organisation (WHO) and the European Commission. For rapid antigen tests, this includes a clinical sensitivity of at least 80% (for specimens collected within 7 days of symptom onset) and a clinical specificity of at least 98%.

COVID-19 self-tests (home use) approved by TGA

*Clicking on the name of the test will link to the instructions on how to use it.

Easy Read factsheets on how to do a rapid test have been published by the Department of Health:

PDF Instructions on how to use the test are provided as a supplementary resource for the visually read tests listed below and do not meet disability access requirements. 

Topics

Help us improve this page